Venture Life Group PLC Trading update (3225P)
09 Giugno 2020 - 8:00AM
UK Regulatory
TIDMVLG
RNS Number : 3225P
Venture Life Group PLC
09 June 2020
9 June 2020
Venture Life Group plc
("Venture Life" the "Company" or the "Group")
Trading update
Since the start of the year, Venture Life has made various
announcements providing updates on the positive trading that the
Company achieved. These have included an order book significantly
ahead of that at the same time last year and the signing of an
exclusive EUR168 million agreement with the Company's existing
Chinese partner for a number of its products, one of which is
Dentyl, with orders in excess of EUR7 million for delivery in 2020.
At the same time, all other areas of the business have traded well
and the Company's hand sanitising gel brand (DISINPLUS Ô ) is
seeing good demand.
In addition, the Company is pleased to announce that it has
extended its commercial relationship with Alliance Pharma and has
been appointed as a second manufacturer of Alliance's Kelo-Cote
products. This is an extension in scope to the existing commercial
arrangement between the two companies, which currently runs until
the end of 2026.
Taking these positive developments together, the Company is
pleased to announce that it is confident that it will comfortably
exceed market expectations for this year.
This announcement contains inside information.
Jerry Randall, CEO of Venture Life said , "I am proud of how the
Company has operated through a challenging period and am delighted
with our performance this year. I must pay tribute to the
dedication of all our employees in the Group, especially those
based at Biokosmes in Northern Lombardy, who have not only kept our
business operating in very difficult circumstances, but have also
continued to grow the business and bring more opportunities into
the Group.
"I am also delighted that the team at Alliance have again
extended their business relationship with us, and with the
confidence and trust they have in us as one of their key strategic
suppliers. Biokosmes has been manufacturing products that sit
within the Alliance portfolio since 2001, and Alliance are an
extremely valued customer of the Venture Life Group."
For further information, please contact:
+44 (0) 1344
Venture Life Group PLC 578004
Jerry Randall, Chief Executive Officer
Andrew Waters, Chief Financial Officer
+44 (0) 20 7397
Cenkos Securities plc (Nomad and Broker) 8900
Stephen Keys / Mark Connelly / Cameron MacRitchie
(Corporate Finance)
Russell Kerr / Michael Johnson (Sales)
About Venture Life ( www.venture-life.com )
Venture Life is an international consumer self-care company
focused on developing, manufacturing and commercialising products
for the global self-care market. With operations in the UK, The
Netherlands and Italy, the Group's product portfolio includes some
key products such as the UltraDEX and Dentyl oral care product
ranges, food supplements for maintaining brain function, medical
devices for women's intimate healthcare, fungal infections and
proctology, and dermo-cosmetics for addressing the signs of
ageing.
The products, which are typically recommended by pharmacists or
healthcare practitioners, are available primarily through
pharmacies and grocery multiples. In the UK and The Netherlands,
these are supplied direct by the company to retailers, elsewhere
they are supplied by the Group's international distribution
partners.
Through its Development & Manufacturing business in Italy,
Biokosmes, the Group also provides development and manufacturing
services to companies for consumer healthcare products, primarily
medical devices.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
TSTFLFSTRVITIII
(END) Dow Jones Newswires
June 09, 2020 02:00 ET (06:00 GMT)
Grafico Azioni Venture Life (LSE:VLG)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Venture Life (LSE:VLG)
Storico
Da Apr 2023 a Apr 2024